Investor Type | Firm |
Type of Fund | Corporate VC |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Consumer • Pharmaceutical (& Medicine) |
Stages | Seed, Startup, Early Stage, Series A, Series B |
Investing | United States • Germany • France • Switzerland • Denmark • Hong Kong • Israel • Belgium • Austria • Europe |
Investment Range | $3,300,000 - $17,000,000 |
Investment Sweet Spot | $8,500,000 |
Assets Under Management | $100,000,000 |
Boehringer Ingelheim Venture Fund is the corporate venture capital arm of Boehringer Ingelheim. The firm invests in companies operating in the oncology, biologics, genetherapy, therapeutics and healthcare sectors. It is based in Ingelheim am Rhein, Germany and was founded in 2010.